Sai Abhishek is a Vice President at Enavate Sciences, where he focuses on prospecting, due diligence, investment execution and supporting our partner companies to accelerate innovation. Prior to joining Enavate, he was Director of Portfolio Strategy and Business Development at Code Biotherapeutics. Previously, he was an investor on the Healthcare Team at New Enterprise Associates (NEA), where he focused on biopharma investments and served as a board observer for Affinia Therapeutics, Shape Therapeutics and MBX Biosciences. He started his career in the Global Healthcare Investment Banking Group at Credit Suisse.

Sai graduated from the Wharton School at the University of Pennsylvania with a B.S. in Economics with concentrations in Finance and Statistics as well as a minor in Biology.

Return to Team